Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
CD40 agonist
Description:
A CD40 agonist is an agent that activates the CD40 receptor, used to stimulate immune responses in contexts such as cancer therapy.
Primary topic:
Cancer Immunotherapy and Biomarkers (28%)
Related topics:
Cancer Immunotherapy and Biomarkers (28%),
Immunotherapy and Immune Responses (24%),
Pancreatic and Hepatic Oncology Research (11%),
Immune cells in cancer (8%)
OpenAlex ID:
keywords/cd40-agonist
Cancer Immunotherapy by Dendritic Cells
2008
·
Cornelis J.M. Melief
·
Immunity
·
553
PDF
Cancer immunoediting by the innate immune system in the absence of adaptive immunity
2012
·
Timothy O’Sullivan
, Robert Saddawi-Konefka
, et al.
·
The Journal of Experimental Medicine
·
406
PDF
Combined TLR and CD40 Triggering Induces Potent CD8+ T Cell Expansion with Variable Dependence on Type I IFN
2004
·
Cory L. Ahonen
, Christie L. Doxsee
, et al.
·
The Journal of Experimental Medicine
·
390
PDF
Anti–Cytotoxic T-Lymphocyte Antigen-4 Antibody: The First in an Emerging Class of Immunomodulatory Antibodies for Cancer Treatment
2008
·
Lawrence Fong
, Eric J. Small
·
Journal of Clinical Oncology
·
341
Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6Clow F4/80+ Extratumoral Macrophages
2015
·
Gregory L. Beatty
, Rafael Winograd
, et al.
·
Gastroenterology
·
317
The Immune Revolution: A Case for Priming, Not Checkpoint
2018
·
Robert H. Vonderheide
·
Cancer Cell
·
308
PDF
IFNγ and CCL2 Cooperate to Redirect Tumor-Infiltrating Monocytes to Degrade Fibrosis and Enhance Chemotherapy Efficacy in Pancreatic Carcinoma
2016
·
Kristen B. Long
, Whitney L. Gladney
, et al.
·
Cancer Discovery
·
293
TNF-α is critical for antitumor but not antiviral T cell immunity in mice
2007
·
Thomas Calzascia
, Marc Pellegrini
, et al.
·
Journal of Clinical Investigation
·
283
PDF
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
2018
·
Sabine Hoves
, Chia-Huey Ooi
, et al.
·
The Journal of Experimental Medicine
·
232
Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies
2015
·
E. Gabriela Chiorean
, Andrew Coveler
·
Drug Design Development and Therapy
·
232
PDF
Prospect of Targeting the CD40 Pathway for Cancer Therapy
2007
·
Robert H. Vonderheide
·
Clinical Cancer Research
·
206
PDF
Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication
2004
·
Geertje J D van Mierlo
, Zita F H M Boonman
, et al.
·
The Journal of Immunology
·
194
PDF
Type 1 conventional dendritic cells are systemically dysregulated early in pancreatic carcinogenesis
2020
·
Jeffrey H. Lin
, Austin P. Huffman
, et al.
·
The Journal of Experimental Medicine
·
182
PDF
Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists
2016
·
Gregory L. Beatty
, Yan Li
, et al.
·
Expert Review of Anticancer Therapy
·
176
Combined TLR/CD40 Stimulation Mediates Potent Cellular Immunity by Regulating Dendritic Cell Expression of CD70 In Vivo
2007
·
Phillip J Sanchez
, Jennifer A McWilliams
, et al.
·
The Journal of Immunology
·
171
CD40-mediated immune cell activation enhances response to anti-PD-1 in murine intrahepatic cholangiocarcinoma
2020
·
Laurence P. Diggs
, Benjamin Ruf
, et al.
·
Journal of Hepatology
·
159
Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.
1995
·
A Durandy
, G De Saint Basile
, et al.
·
The Journal of Immunology
·
153
CD40 immunotherapy for pancreatic cancer
2013
·
Robert H. Vonderheide
, David L. Bajor
, et al.
·
Cancer Immunology Immunotherapy
·
128
mAbs to Bacillus anthracis capsular antigen for immunoprotection in anthrax and detection of antigenemia
2004
·
Thomas R. Kozel
, William J. Murphy
, et al.
·
Proceedings of the National Academy of Sciences
·
120
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005
·
Kang Liu
, Juliana Idoyaga
, et al.
·
The Journal of Experimental Medicine
·
115
PDF
Combinatorial approach to cancer immunotherapy: strength in numbers
2016
·
Anna E Vilgelm
, Douglas B Johnson
, et al.
·
Journal of Leukocyte Biology
·
114
PDF
Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain
2017
·
Manisha Singh
, Christina Vianden
, et al.
·
Nature Communications
·
112
PDF
A Phase I Study of APX005M and Cabiralizumab with or without Nivolumab in Patients with Melanoma, Kidney Cancer, or Non–Small Cell Lung Cancer Resistant to Anti-PD-1/PD-L1
2021
·
Sarah A. Weiss
, Dijana Djureinovic
, et al.
·
Clinical Cancer Research
·
111
Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia
2014
·
Sylvain Audia
, Marzia Rossato
, et al.
·
Blood
·
105
Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross‐tolerance
2014
·
Vincent Flacher
, Christoph H Tripp
, et al.
·
EMBO Molecular Medicine
·
105
PDF
Show more works
View as search
Works count:
488
Citation count:
9,656
Year
Topic
Type